DEERFIELD, MA: Takeda has hired Molly Rabinovitz Stock as the US business unit storyteller.
“There’s nothing better than having the chance to work alongside people I’ve loved working with in an agency for the past seven years and for a company I truly admire,” Stock said. through LinkedIn.
She could not be reached for further comment.
“I look forward to helping Takeda and the USBU continue to fulfill its mission to bring better health and a brighter future,” Stock added.
Prior to joining Takeda, Stock spent over 14 years at Real Chemistry. Most recently, she served as practice leader, managing multimillion-dollar accounts in the pharmaceutical industry, according to her LinkedIn account.
“We thank [Stock] for his valuable contributions to our team during his tenure at Real Chemistry, and we wish him the best in this new chapter. We are happy to be able to continue working with her; it will now be in its new role as one of our customers,” a Real Chemistry spokesperson said. The spokesperson added that Real Chemistry is “always on the lookout for great talent” as it continues to grow and develop.
Stock also worked at GolinHarris, before the company was renamed Golin, Northwestern Memorial Hospital and Edelman.
Based in the United States in Deerfield, Takeda also has another Massachusetts office in Cambridge, as well as locations in San Diego, New York and Minneapolis. Takeda is focusing its research and development on oncology, rare genetics and hematology, neuroscience and gastroenterology, as well as targeted investments in plasma-derived therapies and vaccines, it said in a statement.
Already registered with us?
Sign up now to enjoy more free articles and e-newsletters